674 related articles for article (PubMed ID: 18187234)
1. Amyloid-beta precursor protein mediates neuronal toxicity of amyloid beta through Go protein activation.
Sola Vigo F; Kedikian G; Heredia L; Heredia F; Añel AD; Rosa AL; Lorenzo A
Neurobiol Aging; 2009 Sep; 30(9):1379-92. PubMed ID: 18187234
[TBL] [Abstract][Full Text] [Related]
2. Secreted amyloid precursor protein and holo-APP bind amyloid beta through distinct domains eliciting different toxic responses on hippocampal neurons.
Kedikian G; Heredia F; Salvador VR; Raimunda D; Isoardi N; Heredia L; Lorenzo A
J Neurosci Res; 2010 Jun; 88(8):1795-803. PubMed ID: 20155808
[TBL] [Abstract][Full Text] [Related]
3. Amyloid beta interacts with the amyloid precursor protein: a potential toxic mechanism in Alzheimer's disease.
Lorenzo A; Yuan M; Zhang Z; Paganetti PA; Sturchler-Pierrat C; Staufenbiel M; Mautino J; Vigo FS; Sommer B; Yankner BA
Nat Neurosci; 2000 May; 3(5):460-4. PubMed ID: 10769385
[TBL] [Abstract][Full Text] [Related]
4. Amyloid precursor protein and amyloid beta-peptide bind to ATP synthase and regulate its activity at the surface of neural cells.
Schmidt C; Lepsverdize E; Chi SL; Das AM; Pizzo SV; Dityatev A; Schachner M
Mol Psychiatry; 2008 Oct; 13(10):953-69. PubMed ID: 17726461
[TBL] [Abstract][Full Text] [Related]
5. Deposition of amyloid fibrils promotes cell-surface accumulation of amyloid beta precursor protein.
Heredia L; Lin R; Vigo FS; Kedikian G; Busciglio J; Lorenzo A
Neurobiol Dis; 2004 Aug; 16(3):617-29. PubMed ID: 15262274
[TBL] [Abstract][Full Text] [Related]
6. Characterization of V642I-AbetaPP-induced cytotoxicity in primary neurons.
Niikura T; Yamada M; Chiba T; Aiso S; Matsuoka M; Nishimoto I
J Neurosci Res; 2004 Jul; 77(1):54-62. PubMed ID: 15197738
[TBL] [Abstract][Full Text] [Related]
7. APP/Go protein Gβγ-complex signaling mediates Aβ degeneration and cognitive impairment in Alzheimer's disease models.
Bignante EA; Ponce NE; Heredia F; Musso J; Krawczyk MC; Millán J; Pigino GF; Inestrosa NC; Boccia MM; Lorenzo A
Neurobiol Aging; 2018 Apr; 64():44-57. PubMed ID: 29331876
[TBL] [Abstract][Full Text] [Related]
8. The consequences of reducing expression of the alpha7 nicotinic receptor by RNA interference and of stimulating its activity with an alpha7 agonist in SH-SY5Y cells indicate that this receptor plays a neuroprotective role in connection with the pathogenesis of Alzheimer's disease.
Qi XL; Nordberg A; Xiu J; Guan ZZ
Neurochem Int; 2007; 51(6-7):377-83. PubMed ID: 17493709
[TBL] [Abstract][Full Text] [Related]
9. Mice knock out for the histone acetyltransferase p300/CREB binding protein-associated factor develop a resistance to amyloid toxicity.
Duclot F; Meffre J; Jacquet C; Gongora C; Maurice T
Neuroscience; 2010 May; 167(3):850-63. PubMed ID: 20219649
[TBL] [Abstract][Full Text] [Related]
10. Etazolate, a neuroprotective drug linking GABA(A) receptor pharmacology to amyloid precursor protein processing.
Marcade M; Bourdin J; Loiseau N; Peillon H; Rayer A; Drouin D; Schweighoffer F; Désiré L
J Neurochem; 2008 Jul; 106(1):392-404. PubMed ID: 18397369
[TBL] [Abstract][Full Text] [Related]
11. Rac1 inhibition negatively regulates transcriptional activity of the amyloid precursor protein gene.
Wang PL; Niidome T; Akaike A; Kihara T; Sugimoto H
J Neurosci Res; 2009 Jul; 87(9):2105-14. PubMed ID: 19267423
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-beta signaling pathway as a therapeutic target in neurodegeneration.
Wyss-Coray T
J Mol Neurosci; 2004; 24(1):149-53. PubMed ID: 15314264
[TBL] [Abstract][Full Text] [Related]
13. Alzheimer's disease-associated amyloid beta interacts with the human serine protease HtrA2/Omi.
Park HJ; Seong YM; Choi JY; Kang S; Rhim H
Neurosci Lett; 2004 Feb; 357(1):63-7. PubMed ID: 15036614
[TBL] [Abstract][Full Text] [Related]
14. Caspase inhibition therapy abolishes brain trauma-induced increases in Abeta peptide: implications for clinical outcome.
Abrahamson EE; Ikonomovic MD; Ciallella JR; Hope CE; Paljug WR; Isanski BA; Flood DG; Clark RS; DeKosky ST
Exp Neurol; 2006 Feb; 197(2):437-50. PubMed ID: 16300758
[TBL] [Abstract][Full Text] [Related]
15. Calcium and neuronal injury in Alzheimer's disease. Contributions of beta-amyloid precursor protein mismetabolism, free radicals, and metabolic compromise.
Mattson MP
Ann N Y Acad Sci; 1994 Dec; 747():50-76. PubMed ID: 7847692
[TBL] [Abstract][Full Text] [Related]
16. Binding of cystatin C to Alzheimer's amyloid beta inhibits in vitro amyloid fibril formation.
Sastre M; Calero M; Pawlik M; Mathews PM; Kumar A; Danilov V; Schmidt SD; Nixon RA; Frangione B; Levy E
Neurobiol Aging; 2004 Sep; 25(8):1033-43. PubMed ID: 15212828
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the toxic mechanism triggered by Alzheimer's amyloid-beta peptides via p75 neurotrophin receptor in neuronal hybrid cells.
Tsukamoto E; Hashimoto Y; Kanekura K; Niikura T; Aiso S; Nishimoto I
J Neurosci Res; 2003 Sep; 73(5):627-36. PubMed ID: 12929130
[TBL] [Abstract][Full Text] [Related]
18. Progressive neuronal loss and behavioral impairments of transgenic C57BL/6 inbred mice expressing the carboxy terminus of amyloid precursor protein.
Lee KW; Im JY; Song JS; Lee SH; Lee HJ; Ha HY; Koh JY; Gwag BJ; Yang SD; Paik SG; Han PL
Neurobiol Dis; 2006 Apr; 22(1):10-24. PubMed ID: 16289866
[TBL] [Abstract][Full Text] [Related]
19. Accelerated amyloid deposition, neurofibrillary degeneration and neuronal loss in double mutant APP/tau transgenic mice.
Ribé EM; Pérez M; Puig B; Gich I; Lim F; Cuadrado M; Sesma T; Catena S; Sánchez B; Nieto M; Gómez-Ramos P; Morán MA; Cabodevilla F; Samaranch L; Ortiz L; Pérez A; Ferrer I; Avila J; Gómez-Isla T
Neurobiol Dis; 2005 Dec; 20(3):814-22. PubMed ID: 16125396
[TBL] [Abstract][Full Text] [Related]
20. Role of the APP promoter in Alzheimer's disease: cell type-specific expression of the beta-amyloid precursor protein.
Lahiri DK; Ge YW
Ann N Y Acad Sci; 2004 Dec; 1030():310-6. PubMed ID: 15659812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
